Trial ID or NCT#





We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.

Official Title

Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


James L. Zehnder, M.D.
Hematologist, Leukemia specialist, Medical oncologist
Professor of Pathology (Research) and of Medicine (Hematology) at the Stanford University Medical Center
Jason Gotlib
Hematologist, Medical oncologist, Leukemia specialist
Professor of Medicine (Hematology) at the Stanford University Medical Center
Scott Boyd, MD PhD
Pathologist, Hematopathologist
Associate Professor of Pathology

Contact us to find out if this trial is right for you.


Jason D Merker
(650) 922-1885